Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

3:05pm EDT
Change (% chg)

$2.74 (+1.40%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ILMN.OQ


Illumina, Inc. (Illumina) is engaged in production development of sequencing-and array-based solutions for genetic analysis. It offers integrated systems, consumables and analysis tools for genetic analysis. Illumina also manufactures sequencing and array platforms, reagent kits and scanning equipment. The Company's customers... (more)


Beta: 1.02
Market Cap(Mil.): $28,317.79
Shares Outstanding(Mil.): 144.70
Dividend: --
Yield (%): --


  ILMN.OQ Industry Sector
P/E (TTM): 59.84 15.06 34.00
EPS (TTM): 3.27 -- --
ROI: 18.11 3.19 14.57
ROE: 33.79 4.31 15.46
Search Stocks

Illumina partners with private equity firm on gene JV: sources

- Gene-sequencing giant Illumina Inc, private equity firm Warburg Pincus LLC and venture capital firm Sutter Hill Ventures have agreed to invest $100 million to seed a new consumer-facing human genome platform called Helix, according to people familiar with the deal.

18 Aug 2015

BRIEF-Merck Serono, Illumina to collaborate on cancer diagnostics

* Merck Serono and Illumina enter strategic collaboration for diagnostics in oncology

10 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : Wright Reports
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks